Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Biodesix Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of BDSX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders2937+8
Shares16.8M17.3M+438.5K (+2.6%)
Value$20.7M$27.7M+$6.96M (+33.6%)

New holders (11)

Institutions that held Biodesix Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to BDSX in Q3 2023
InstitutionSharesValue% of portfolio
Cetera Advisor Networks LLC78,000$128.7K0.00%
HRT Financial LP62,525$103.0K0.00%
Citadel Advisors LLC44,623$73.6K0.00%
Oracle Investment Management Inc42,076$69.4K0.11%
Millennium Management LLC33,599$55.4K0.00%
Tower Research Capital LLC (TRC)31,602$52.1K0.00%
Prudential Financial Inc24,800$40.9K0.00%
Qube Research & Technologies Ltd6,366$10.5K0.00%
Bank of America Corp1,493$2.46K0.00%
JPMorgan Chase & Co11$180.00%
Opaleye Management Inc.455,573––

Sold out (3)

Institutions that held Biodesix Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of BDSX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Advisor Group Holdings, Inc.973$1.20K
Barclays PLC247$304
Gradient Investments LLC100$123